Signaling pathways most affected in hiPSC-CMs were related to cell cycle (i.e., pathways in cancer, PI3K-Akt signaling pathway), immune system (i.e., interleukin-2 signaling pathway, T-cell receptor regulation of apoptosis), hemostasis and platelet activation. The gene discussed is IL2; the disease is cancer.